# ClinicalTrials.gov record NCT01354405

> PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide.

- Evidence object: `story:clinicaltrials-gov-nct01354405-lanreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-07-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01354405-lanreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01354405-lanreotide-v1.json
- Content SHA-256: `1ab58e4a2538a03979f906c7649ff867c6f697d58b36991b042c5f8e783ea09d`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01354405 ([`ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2`](#source-ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide. ([`ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2`](#source-ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide. ([`ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2`](#source-ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2`](#source-ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2))

## Sources

<a id="source-ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2"></a>
- **ClinicalTrials.gov record NCT01354405 · retained source version 2014-07-09:73f5a87d9ec20517cd117812ffdecdcabf42001280f69b3b2427f9eb064504d1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01354405) (`ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01354405." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01354405-lanreotide-v1.json SHA-256: 1ab58e4a2538a03979f906c7649ff867c6f697d58b36991b042c5f8e783ea09d.